Medcent Pharma LLP
About Medcent Pharma LLP
Data last updated:
Medcent Pharma LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 October 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAU-3666. Its GSTIN is 36ABPFM1362D1ZB (Telangana).
The LLP has a total obligation of contribution of ₹1.3 Cr. It is led by designated partners Rajesh Ganesuni and Maneesha Chintakunta.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 3rd Floor Plot No 9/17/A&B Pinnacle Towers Road No 6 Ida Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹2.26 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹26.74 Lakh (net margin -11.8%) and EBITDA of ₹15.24 Lakh (EBITDA margin 6.7%).
The LLP has about 25 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address3rd Floor Plot No 9/17/A&B Pinnacle Towers Road No 6 Ida Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Medcent Pharma LLP FY 2025 filings available
Medcent Pharma LLP reported revenue of ₹2.26 Cr (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Medcent Pharma LLP
Revenue rose 39% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medcent Pharma LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | ₹2.26 Cr | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | -₹26.74 Lakh | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medcent Pharma LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | -11.8% | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Medcent Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Medcent Pharma LLP
Medcent Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Ganesuni | Designated Partner | 22 Oct 2020 | 5 Years 11 Months | Current |
| Maneesha Chintakunta Also directs: Aloka Infra LLP | Designated Partner | 22 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Medcent Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medcent Pharma LLP
Medcent Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medcent Pharma LLP
Medcent Pharma LLP has a workforce of 25 employees as of Mar 26, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medcent Pharma LLP
Medcent Pharma LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Maneesha Chintakunta was appointed as Designated Partner on 22 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Medcent Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medcent Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medcent Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medcent Pharma LLP
Medcent Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABPFM1362D1ZB | Telangana | Active | 11 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medcent Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medcent Pharma LLP
Medcent Pharma is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 22 October 2020 (6+ years old) and is registered under LLPIN AAU-3666.
Medcent Pharma reported revenue of ₹2.26 Cr for FY 2024 (up 39% YoY).
Medcent Pharma has 2 current designated partners:
- Rajesh Ganesuni - Designated Partner
- Maneesha Chintakunta - Designated Partner
Medcent Pharma reported a net loss of ₹26.74 Lakh (net margin -11.8%) and EBITDA of ₹15.24 Lakh (EBITDA margin 6.7%) for FY 2024, as per its filed financial statements.
The GSTIN of Medcent Pharma is 36ABPFM1362D1ZB, registered in Telangana.
The LLPIN (Limited Liability Partnership Identification Number) of Medcent Pharma is AAU-3666. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Medcent Pharma was incorporated on 22 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Maneesha Chintakunta was appointed as Designated Partner on 22 Oct 2020. Rajesh Ganesuni was appointed as Designated Partner on 22 Oct 2020.
Yes, Medcent Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Medcent Pharma is at 3rd Floor Plot No 917A&B Pinnacle Towers Road No 6 Ida Nacharam, Hyderabad, Telangana, India – 500076.